| Literature DB >> 32660124 |
Terrence Hanscom1, Mitch McVey1.
Abstract
Double-strand breaks are one of the most deleterious DNA lesions. Their repair via error-prone mechanisms can promote mutagenesis, loss of genetic information, and deregulation of the genome. These detrimental outcomes are significant drivers of human diseases, including many cancers. Mutagenic double-strand break repair also facilitates heritable genetic changes that drive organismal adaptation and evolution. In this review, we discuss the mechanisms of various error-prone DNA double-strand break repair processes and the cellular conditions that regulate them, with a focus on alternative end joining. We provide examples that illustrate how mutagenic double-strand break repair drives genome diversity and evolution. Finally, we discuss how error-prone break repair can be crucial to the induction and progression of diseases such as cancer.Entities:
Keywords: alt-EJ; chromosome rearrangements; microhomology-mediated end joining; polymerase theta; resection
Mesh:
Year: 2020 PMID: 32660124 PMCID: PMC7407515 DOI: 10.3390/cells9071657
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600
Figure 1Categories of end-joining repair. The various forms of end joining are shown according to their mechanistic and genetic requirements. Alternative end joining (alt-EJ) is genetically distinct from canonical NHEJ (cNHEJ). Three models for synthesis-dependent microhomology-mediated end joining (SD-MMEJ) have been proposed, all of which can utilize DNA polymerase theta. In addition, simple MMEJ in metazoans (but not in yeast) requires polymerase theta. These types of MMEJ are grouped together as theta-mediated end joining (TMEJ). In the absence of polymerase theta, breaks can be repaired by a genetically undefined form of MMEJ that results in extremely large deletions.
Figure 2Mutagenic outcomes of homologous recombination. All types of homologous recombination begin with resection to form single-stranded DNA, followed by RAD51-mediated strand invasion. SDSA and DSBR usually use the sister chromatid as a template but the use of the homologous chromosome can result in loss of heterozygosity (SDSA) or mitotic crossovers (DSBR). BIR involves the formation of a mobile D-loop and produces long, single-stranded DNA tracts. BIR can result in loss of heterozygosity and mutations caused by damage in persistent ssDNA. MM-BIR involves multiple rounds of strand invasion, which can cause insertions of heterologous sequences. NAHR occurs when single-stranded DNA invades into a non-allelic template. NAHR can be intrachromosomal or interchromosomal and results in deletions (shown), duplications, and inversions.
Figure 3Factors that influence DSB repair pathway choice. cNHEJ operates throughout the cell cycle. HR, SSA, and alt-EJ require DNA resection and are therefore utilized primarily in S/G2. The required amounts of resection and homology are highest for HR and decrease for SSA and alt-EJ. RPA inhibits SSA and alt-EJ by preventing annealing of complementary sequences in single-stranded DNA.
Cancers reliant upon error-prone DSB repair. For each type of cancer/disease, the repair pathway that is impaired, genetic background, and the types of genomic mutations observed are listed. The druggable targets column indicates therapeutic approaches that may be used to exploit a synthetic lethal interaction. TD = tandem duplications, LOH = loss of heterozygosity.
| Cancer/Disease | Affected Repair Pathway | Genetic Background | Drugable Targets | Effects on Genome | References |
|---|---|---|---|---|---|
| Breast, ovarian, melanoma, prostate, pancreatic | HR | BRCA1 deficient | POLQ, PARP1 | Translocations, TDs, LOH, point mutations | [ |
| Breast, ovarian | HR | BRCA2 deficient | POLQ, PARP1 | Translocations, LOH, TDs, point mutations | [ |
| Epithelial ovarian cancers | HR | FANCD2 deficient, Increased expression of POLQ | PARP1, FANCD2, POLQ | Chromosomal aberrations, nonsynonymous mutations | [ |
| Breast, ovarian, Fanconi anemia | HR | PALB2 deficient | PARP1 | Translocations, LOH, TDs, point mutations | [ |
| Breast, stomach, prostate | HR | CHD1 deficient, | PARP1, PTEN | Translocations, LOH, TDs, point mutations | [ |
| Breast, ovarian, Fanconi anemia | HR | RAD51C deficient | PARP1 | Genomic instability, aneuploidy, chromosome aberrations | [ |
| Breast, ovarian, Fanconi anemia | HR | RAD51D deficient | PARP1 | Large deletions, genomic instability | [ |
| Chronic myeloid leukemia | HR | BCR-ABL (constitutively active tyrosine kinase), increased expression of LIG3a, PARP1, and WRN | PARP1 combined with DNA ligase inhibitors | Translocations, LOH, TDs, point mutations | [ |
| Lynch Syndrome, colorectal, endometrial, ovarian, gastric, urinary, small bowel, pancreatic, prostate | MMR, HR | MLH1, MSH2, MSH6, PMS2 deficient | PARP1 | Point mutations, microsatellite instability | [ |
| High grade bladder tumors, colon | cNHEJ | KU, DNA-PK, or XRCC4 deficient | Unknown | Deletions (<125 bp on average) and microhomology at repair junctions | [ |
| Multiple myeloma, leukemia, pro B-cell lymphoma | cNHEJ | KU and P53 deficient | Unknown | Rearrangements and gene amplifications, nonreciprocal translocations, increased microhomologies at repair junctions | [ |
| MCF7 breast cancer | cNHEJ | Reduced levels of DNA LIG4 Increased levels of DNA LIG3a and PARP1 | PARP1 combined with DNA ligase inhibitors | Large deletions, translocations | [ |
| Acute myeloid leukemia | cNHEJ | Decreased expression of KU proteins | Unknown | TDs, microhomology at repair junctions, deletions | [ |
| Neuroblastoma | cNHEJ | LIG4 and Artemis deficient | PARP1 | Translocations, TDs | [ |
| Non-BRCA1/2 breast cancer | cNHEJ | XRCC4 deficient | Unknown | Translocations | [ |
Figure 4Mutagenic outcomes of Cas9-mediated genome editing. (A) Cas9-mediated double-strand breaks are usually blunt-ended and can be repaired inaccurately by cNHEJ and alt-EJ. Occasionally, Cas9 leaves 5′ single-stranded overhangs that are filled in, resulting in a single nucleotide insertion. (B) 3′ overhangs produced by Cas9 nickases are often repaired by alt-EJ, creating large, templated insertions. In contrast, 5′ overhangs are processed by nucleases to produce substrates suitable for alt-EJ and HR, sometimes resulting in large deletions.